These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 18371533
1. Association of analgesic use with prevalence of albuminuria and reduced GFR in US adults. Agodoa LY, Francis ME, Eggers PW. Am J Kidney Dis; 2008 Apr; 51(4):573-83. PubMed ID: 18371533 [Abstract] [Full Text] [Related]
2. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213 [Abstract] [Full Text] [Related]
5. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG. Nephrol Dial Transplant; 2009 Jun; 24(6):1908-18. PubMed ID: 19155536 [Abstract] [Full Text] [Related]
6. Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease. Baber U, Mann D, Shimbo D, Woodward M, Olin JW, Muntner P. Am J Cardiol; 2009 Nov 15; 104(10):1446-51. PubMed ID: 19892066 [Abstract] [Full Text] [Related]
11. Association of sleep-related problems with CKD in the United States, 2005-2008. Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, Rolka D, Saydah S, Powe NR, CDC CKD Surveillance Team. Am J Kidney Dis; 2011 Oct 15; 58(4):554-64. PubMed ID: 21816524 [Abstract] [Full Text] [Related]
12. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III). Clase CM, Kiberd BA, Garg AX. Nephron Clin Pract; 2007 Oct 15; 105(4):c178-84. PubMed ID: 17347576 [Abstract] [Full Text] [Related]
14. Relationship of uric acid with progression of kidney disease. Chonchol M, Shlipak MG, Katz R, Sarnak MJ, Newman AB, Siscovick DS, Kestenbaum B, Carney JK, Fried LF. Am J Kidney Dis; 2007 Aug 15; 50(2):239-47. PubMed ID: 17660025 [Abstract] [Full Text] [Related]
15. Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Charlton-Menys V, DeMicco DA, Fuller JH, CARDS Investigators. Am J Kidney Dis; 2009 Nov 15; 54(5):810-9. PubMed ID: 19540640 [Abstract] [Full Text] [Related]
19. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study. Stengel B, Jaussent I, Guiserix J, Bourgeon B, Papoz L, Favier F, REDIA Study Group. Diabetes Metab; 2007 Dec 15; 33(6):444-52. PubMed ID: 18006351 [Abstract] [Full Text] [Related]
20. Association between chronic kidney disease and carotid intima-media thickening in individuals with hypertension and impaired glucose metabolism. Ishizaka N, Ishizaka Y, Toda E, Koike K, Seki G, Nagai R, Yamakado M. Hypertens Res; 2007 Nov 15; 30(11):1035-41. PubMed ID: 18250552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]